The European Commission is providing 13 research groups in Europe with $7.8 million to create biomarker-based tools for evaluating the health of patients who have undergone kidney transplants. The consortium, also known as BIOMARGIN, will develop noninvasive ways to detect allograft lesions and improve the survival of the kidney and patient over the long term.
EU awards $7.8M for kidney transplant biomarker development
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||